3 Explosive Stocks With High Short Interest
High short interest can help investors identify potential high risks. And, it can also be a sign of a possible short squeeze situation – especially if the stock in question has been rocketing higher.In fact, here are three high short…
High short interest can help investors identify potential high risks. And, it can also be a sign of a possible short squeeze situation – especially if the stock in question has been rocketing higher.
In fact, here are three high short interest stocks you may want to pay attention to.
Viking Therapeutics (NASDAQ: VKTX): | VKTX Price Prediction With 23% of its float short, Viking Therapeutics has been gaining momentum. In fact, since bottoming out at around $25, it’s now up to $35.22 and climbing. Fueling upside, analysts at Canaccord initiated coverage of the obesity treatment stock with a buy rating and a price target of $106 a share.
The company is also seeing progress in its Phase 3 VANQUISH trial for the injectable obesity drug VK2735. As noted in a company press release, “The company expects to complete enrollment in the VANQUISH-1 study by the end of 2025, with completion of enrollment in VANQUISH-2 expected in 1Q26.”
NuScale Power (NYSE: SMR): With a short interest of 22.6%, NuScale has also been explosive. Since bottoming out at $32.50, SMR is now back to $43.17 and rallying. For one, there’s growing demand for nuclear energy, especially with explosive demand from data centers. Two, analysts at Cantor Fitzgerald just initiated coverage of SMR with an overweight rating and a price target of $55 a share.
Lemonade (NYSE: LMND): With a short interest of 25%, Lemonade has been just as explosive. Since bottoming out at around $47.50, LMND is now at $60.71 and could also push aggressively higher. Analysts believe Lemonade’s earnings on November 5 could send the stock soaring, especially with its exposure to artificial intelligence. By using AI for just about every part of its business, it’s been delivering faster, more efficient, and transparent insurance information.
All of which would help explain why LMND was able to grow its policyholder base to 2.7 million at the end of the second quarter. That was 24% year-over-year growth, which we expect to improve even more moving forward.
Contact [email protected] for any questions or corrections.
Ian Cooper is a veteran market analyst and investment strategist with more than 20 years of experience covering stocks, commodities, and macro trends. Since 1999, he has helped investors identify market opportunities using a blend of technical analysis, fundamental research, and market sentiment.
He is the creator of the ADD News Flow Strategy, which focuses on trading market reactions to major news events and investor psychology. Cooper was also among the analysts who warned about the 2008 financial crisis and major financial institution collapses ahead of the broader market.
Before joining 247 Wall St., Cooper wrote extensively for InvestorPlace and other financial publications, covering market trends, trading strategies, and investment opportunities.
